more frequent side effects
first degree
atrioventricular block
comprehensive list of adverse effects
clinical trials
safety of this drug
hiv
antiretroviral therapy-naive patients
individual components with other antiretrovirals
least weeks
trial
atazanavir
cobicistat
emtricitabine-tenofovir
cobicistat-boosted group
trial
atazanavir
ritonavir
emtricitabine-tenofovir
ritonavir-boosted group
cobicistat-boosted group
common side effects
jaundice
ocular icterus
nausea
ritonavir-boosted group
common side effects
jaundice
ocular icterus
nausea
diarrhea
study treatment
side effects
patients
cobicistat
ritonavir-boosted groups
side effects
clinical trials
least moderate intensity
grade
manufacturer product information for atazanavir
cobicistat
additional safety information
increases in total bilirubin
times
upper limit of normal
uln
patients in the cobicistat-boosted group
ritonavir-boosted group
increased alt
uln
ast
uln
ggt
uln
patients in the cobicistat-boosted group
patients in the ritonavir-boosted group
jaundice
cobicistat-boosted group
grades
grades
ritonavir-boosted group
grades
grades
most patients
taking atazanavir
asymptomatic elevations in indirect
bilirubin
inhibition of ugt
hyperbilirubinemia
discontinuation of atazanavir
increased total bilirubin
jaundice
increased alt
ast
ggtatazanavir
bilirubin/hyperbilirubinemia
udp-glucuronosyl transferase
ugt
jaundice
increased alt
ast
ggt-postmarketing reports
hepatic function abnormalities
cholelithiasis
cholecystitis
cholestasis
ocular icterus
cobicistat-boosted group
grades
grades
ritonavir-boosted group
grades
grades
ocular icterus
atazanavir
ocular icterus
nausea
increased lipase
serum amylasefrequency
diarrhea
vomiting
upper abdominal painatazanavir
nausea
diarrhea-common
increased lipase
serum
amylase-postmarketing reports
pancreatitis
nausea
cobicistat-boosted group
grades
grades
ritonavir-boosted group
grades
grades
diarrhea
grades
patients in the ritonavir-boosted group
increased serum amylase
uln
patients in the cobicistat-boosted
ritonavir-boosted groups
serum amylase
uln
lipase
increased lipase
grades
patients in the cobicistat-boosted
ritonavir-boosted groups
rash
rash events
allergic dermatitis
drug hypersensitivity
generalized pruritus
eosinophilic pustular folliculitis
rash
generalized rash
macular rash
maculopapular rash
morbilliform rash
papular rash
urticaria
atazanavir
rash events-frequency
stevens-johnson syndrome
erythema multiforme
toxic skin eruptions
drug rash with eosinophilia
systemic symptoms
dress
syndrome
mild-to-moderate maculopapular skin eruptions-postmarketing reports
alopecia
maculopapular rash
pruritus
angioedema
rash events
grades
patients in the cobicistat-boosted
ritonavir-boosted groups
increased creatine kinasefrequency
rhabdomyolysisatazanavir
increased creatine kinase-postmarketing reports
increased creatine kinase
uln
patients in the cobicistat-boosted
ritonavir-boosted groups
nephrolithiasis
atazanavir
clinical trials
nephrolithiasis
patients in the cobicistat-boosted group
patients in the ritonavir-boosted group
onset of nephrolithiasis
weeks in the cobicistat-boosted group
clinical trials
serum creatinine
crcl decreases
therapy in the cobicistat-boosted group after which
weeks of therapy
egfr
crcl
change
ml/min in the cobicistat-boosted group
ml/min in the ritonavir-boosted group
renal impairment
including
acute renal failure
fanconi syndrome
cobicistat
regimen
containing tenofovir
clinical trials over weeks
n =-rrb-
patients
using atazanavir
cobicistat
tenofovir
discontinued therapy
renal side effect
patients
laboratory findings
proximal renal tubulopathy
none of the patients
baseline
renal dysfunction
estimated crcl
ml/min
laboratory findings in these patients
patients
therapy
patients
renal replacement therapy
nephrolithiasisfrequency
decreased estimated crcl
serum creatinine
estimated glomerular filtration rate
egfr
crcl
nephropathy
fanconi syndrome
laboratory findings
proximal renal tubulopathyatazanavir
frequency
decreased egfr-postmarketing reports
nephrolithiasis
interstitial nephritiscobicistat
frequency
decreased estimated crcl
serum creatinine
tubular secretion of creatinine
actual renal glomerular function
egfr
renal impairment
including
acute renal failure
fanconi syndrome
increased urine rbc
rbc/high power field
urine glucose
least mg/dl
patients in the cobicistat-boosted group
patients in the ritonavir-boosted group
hematuria
increased urine rbc
glycosuria
increased urine glucose
atazanavir
increased urine rbc
urine glucose
frequency
total cholesterol
fasted high-density lipoprotein cholesterol
fasted low-density lipoprotein cholesterol
fasted triglyceridesatazanavir
postmarketing reports
new onset diabetes mellitus
exacerbation
preexisting diabetes mellitus
hyperglycemia
diabetic ketoacidosiscombination
antiretroviral therapy
frequency
redistribution/accumulation of body fat
including
central obesity
dorsocervical fat enlargement
peripheral wasting
facial wasting
breast enlargement
cushingoid appearance
frequency
headache
frequency
fatigueatazanavir
postmarketing reports
edema
frequency
depression
abnormal dreams
insomnia
atazanavir
av
block-frequency
prolongation of the pr interval
abnormalities in av conduction
other conduction abnormalities-postmarketing reports
second-degree av block
third-degree av block
bundle branch block
qtc prolongation
atazanavir
frequency
immune reconstitution syndromecombination
antiretroviral therapy
frequency
immune reconstitution syndrome
autoimmune disorders in the setting of immune reconstitution
graves
disease
polymyositis
guillain-barre syndrome
protease inhibitor therapy
frequency
increased bleeding
including
spontaneous skin hematomas
hemarthrosis
hemophiliacs
stomach pain
chills
clay-colored stools
dark urine
dizziness
fever
headache
itching or rash
loss of appetite
nausea
unpleasant breath odor
unusual tiredness
weakness
vomiting of blood
yellow eyes
skin
stomach fullness
tenderness
black, tarry stools
blistering
peeling
loosening of the skin
blood in the urine
chest pain
clay colored stools
decreased appetite
diarrhea
stomach pain
muscle pain
pain in the groin
genitals
difficult urination
recurrent fever
red skin lesions
purple center
red, irritated eyes
sharp back pain
ribs
sore throat
sores
ulcers
white spots in the mouth
lips
swelling of the feet
lower legs
swollen glands
unusual bleeding
bruising